KCP
ACLS icon

Keane Capital Partners’s Axcelis ACLS Stock Holding History

Keane Capital Partners’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-68,884
Closed -$772K – 32
2016
Q1 		$772K Buy
+68,884
New +$704K 2.54% 22

Other funds holding ACLS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Schneider Capital Management Berwyn, Pennsylvania $175M AUM 42.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Keane Capital Partners's ACLS Position: Q2 2016 in Review

Keane Capital Partners sold out of Axcelis (ACLS) in Q2 2016, closing a stake of 68,884 shares — an estimated $772K sold.

Keane Capital Partners first reported a position in ACLS in Q1 2016 and held it in 1 quarter. The position peaked at $772K in Q1 2016. 95 funds tracked by Wall St. Rank hold ACLS as of Q2 2016.

  • Keane Capital Partners reported no remaining Axcelis position as of Q2 2016 after selling out during the quarter.
  • Keane Capital Partners sold 68,884 Axcelis shares in Q2 2016, an estimated $772K.
  • Keane Capital Partners first reported a position in Axcelis in Q1 2016 and held it in 1 quarter.
  • Keane Capital Partners's Axcelis position peaked at $772K in Q1 2016.
  • 95 funds tracked by Wall St. Rank held Axcelis as of Q2 2016.

Based on Keane Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.